In this cohort, HLA-A*03 was shown to be protective,8 and we selected chronic HCV–infected individuals with HLA-A*03 for this study to identify viral adaptations in these individuals that may have affected their infection outcomes. The gene discussed is HLA-A; the disease is infection.